Literature DB >> 31660008

Neuropathy May Be an Independent Risk Factor for Amputation After Lower-Extremity Burn in Adults With Diabetes.

Soman Sen1, Alura Barsun1, Kathleen Romanowski1, Tina Palmieri1, David Greenhalgh1.   

Abstract

IN BRIEF Treatment of lower-extremity burn injuries in adults with diabetes can be complex, and some diabetes-related factors can lead to impaired healing of such wounds, putting patients at risk of amputation. In this retrospective review of adult patients with lower-extremity burns, patients with pre-injury neuropathy and higher A1C levels were more likely to require amputations after their burn injury. The authors conclude that lower-extremity burn injuries in patients with diabetes require close follow-up and possibly referral to a burn specialist for interventions and treatment strategies to offset more serious complications.
© 2019 by the American Diabetes Association.

Entities:  

Year:  2019        PMID: 31660008      PMCID: PMC6794228          DOI: 10.2337/cd18-0066

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN: 0891-8929


  21 in total

Review 1.  Painful diabetic neuropathy.

Authors:  S Tesfaye; P Kempler
Journal:  Diabetologia       Date:  2005-05       Impact factor: 10.122

Review 2.  Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights.

Authors:  Dimitrios Baltzis; Ioanna Eleftheriadou; Aristidis Veves
Journal:  Adv Ther       Date:  2014-07-29       Impact factor: 3.845

Review 3.  Wound healing and its impairment in the diabetic foot.

Authors:  Vincent Falanga
Journal:  Lancet       Date:  2005-11-12       Impact factor: 79.321

4.  Hemoglobin A1c Testing and Amputation Rates in Black, Hispanic, and White Medicare Patients.

Authors:  Bjoern D Suckow; Karina A Newhall; Kimon Bekelis; Adrienne E Faerber; Daniel J Gottlieb; Jonathan S Skinner; David H Stone; Philip P Goodney
Journal:  Ann Vasc Surg       Date:  2016-07-27       Impact factor: 1.466

5.  Distal sensory latency measurement of the superficial radial nerve in normal adult subjects.

Authors:  K Mackenzie; J A DeLisa
Journal:  Arch Phys Med Rehabil       Date:  1981-01       Impact factor: 3.966

Review 6.  Glucose control and diabetic neuropathy: lessons from recent large clinical trials.

Authors:  Lynn Ang; Mamta Jaiswal; Catherine Martin; Rodica Pop-Busui
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

7.  Impact of diabetes on burn injury: preliminary results from prospective study.

Authors:  Suzanne B Schwartz; Michelanne Rothrock; Yolanda Barron-Vaya; Chelsea Bendell; Ameet Kamat; Marianne Midgett; Jill Abshire; Kitra Biebighauser; Lisa F Staiano-Coico; Roger W Yurt
Journal:  J Burn Care Res       Date:  2011 May-Jun       Impact factor: 1.845

8.  A ten-year review of lower extremity burns in diabetics: small burns that lead to major problems.

Authors:  Alura Barsun; Soman Sen; Tina L Palmieri; David G Greenhalgh
Journal:  J Burn Care Res       Date:  2013 Mar-Apr       Impact factor: 1.845

9.  Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration.

Authors:  C A Abbott; L Vileikyte; S Williamson; A L Carrington; A J Boulton
Journal:  Diabetes Care       Date:  1998-07       Impact factor: 19.112

10.  Impact of diabetes and comorbidities on split-thickness skin grafts for foot wounds.

Authors:  Crystal L Ramanujam; David Han; Sharon Fowler; Krista Kilpadi; Thomas Zgonis
Journal:  J Am Podiatr Med Assoc       Date:  2013 May-Jun
View more
  2 in total

1.  Serum Legumain Is Associated with Peripheral Artery Disease in Patients with Type 2 Diabetes.

Authors:  Wen Wei; Shujin Chen; Jianqing Huang; Yan Tong; Jushun Zhang; Xiuping Qiu; Wenrui Zhang; Hangju Chen; Rong Huang; Jin Cai; Mei Tu
Journal:  J Diabetes Res       Date:  2021-12-18       Impact factor: 4.011

Review 2.  Emerging Roles of microRNAs as Biomarkers and Therapeutic Targets for Diabetic Neuropathy.

Authors:  Baoyan Fan; Michael Chopp; Zheng Gang Zhang; Xian Shuang Liu
Journal:  Front Neurol       Date:  2020-10-22       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.